Purpose of Review Breast cancer disparities that exist between high-income countries (HIC) and low-and middle-income countries (LMICs) are also reflected within population subgroups throughout the United States (US). Here we examine three case studies of US populations "left behind" in breast cancer outcomes/equity. Recent Findings African Americans in Chicago, non-Latina White women in Appalachia, and Latinas in the Yakima Valley of Washington State all experience a myriad of factors that contribute to lower rates of breast cancer detection and appropriate treatment as well as poorer survival. These factors, related to the social determinants of health, including geographic isolation, lack of availability of care, and personal constraints, can be addressed with interventions at multiple levels. Summary Although HICs have reduced mortality of breast cancer compared to LMICs, there remain inequities in the US healthcare system. Concerted efforts are needed to ensure that all women have access to equitable screening, detection, treatment, and survivorship resources.
Introduction
Breast cancer is the most common cancer diagnosed among women, as well as the leading cause of cancer death among women worldwide [1] [2] [3] [4] . High-income countries (HICs), including much of Western Europe and North America, demonstrate higher breast cancer incidence rates (71.7 per 100,000), compared to low-and middle-income countries (LMICs) (29.3 per 100,000) [1, 5, 6] . Since the 1990s, incidence rates have decreased or remained stable in HICs-with the exception of some Asian countries-while mortality rates have decreased [5] . Five-year survival among women diagnosed with breast cancer has also increased in most developed nations [7, 8] . Conversely, in LMICs, both incidence and mortality have increased steadily [5] . Five-year relative survival rates in LMICs for women diagnosed with breast cancer at any stage lag behind those of HICs [7] , ranging from 12% in West Africa to nearly 90% in the United States (US), Australia, Canada, and parts of Europe [6] .
Breast cancer disparities that exist between HICs and LMICs-and their causes-are also reflected within population subgroups throughout the US. Although breast cancer incidence rates have remained relatively stable since 1990 and mortality rates have declined approximately 2% per year in the same period in the US [9] , these improvements have not been experienced equitably throughout racial/ethnic groups and geographic locations. Women of color, socially and economically disadvantaged women, and women who live in rural areas suffer from increased mortality after a breast cancer diagnosis.
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Breast Cancer Incidence and Mortality Across Racial/Ethnic Groups and Geographic Locations
The incidence of breast cancer among African American women in the US was lower than that of non-Latina white (NLW) women until 2012, when the rates converged; furthermore, in some southern states, African American women demonstrate higher breast cancer incidence rates and poorer stage-specific survival compared to NLW women [10, 11] . African American in the US are more than twice as likely, and Hispanics are 1.2 times as likely to be diagnosed with metastatic disease than NLWs [12] . Both groups are more likely to be diagnosed with more aggressive sub-types for which 5-year survival is much lower [10, 11, 13] . Among Latina subgroups, Mexican women are nearly twice as likely to present with Stage IV disease than NLWs [14] . Women of all racial/ethnic backgrounds who live in rural areas also experience higher breast cancer mortality than women living in urban areas [15] , despite demonstrating lower incidence [16] .
Poverty and Access to Care: Factors That Influence Late-Stage Diagnosis
Women who receive earlier-stage diagnoses demonstrate longer survival from breast cancer than those who are diagnosed at distant stages. However, in the US, women of all racial and ethnic groups who live in poverty and those who live in rural areas are at increased risk of late-stage diagnosis [14, 15, 17] . Although women with lower incomes are less likely to be diagnosed with breast cancer, lower income is associated with an increased risk of a late-stage breast cancer diagnosis. Specifically, women whose household income is less than $12,500 per year are nearly 2.5 times as likely to be diagnosed with distant stage breast cancer than those whose household income is over $50,000, and those living at or below 100% of the federal poverty level are more than three times as likely to receive a late-stage diagnosis [12] . Mammography capacity is also associated with screening uptake. In the US, mammography facilities are distributed unequally across geographic areas. Mammography capacity has declined across the US as a whole [18] while the percent of women living in low-capacity areas is increasing [19] . Over one quarter of the counties in the US have no mammography facilities at all, and 42 of the 50 states have at least one county without a facility. The counties without mammography facilities are more often rural, have lower population density, and a have high proportion of residents living in poverty [18] .
Affluent NLW women living in urban settings have historically benefited from screening mammography to detect breast cancer at earlier stages and timely access to effective loco-regional and systemic therapies [20] . However, these strategies may not be reaching underserved groups whose awareness and understanding of breast cancer, access to care, and cultural factors differ from those of NLW women. As well, many underserved groups may not obtain such early detection or treatment because it is not available to them geographically, not offered to them, or not covered by insurance.
The barriers to effective early detection and treatment of breast cancer experienced by marginalized groups in the US that contribute to poor breast health outcomes include the social determinants of health, access to care, and cultural factors. These were outlined in a theoretical framework expounded by Warnecke et al. [21] As shown in Fig. 1 , there are multiple levels that contribute to, and are involved in, reducing health disparities. The framework demonstrates that health disparities are affected by a number of levels, including biological antecedents, individual risk behaviors and demographics, the social and physical context of behavior, and social conditions and policies influencing detection and diagnosis. Further, reducing health disparities requires a focus on the numerous levels responsible for the health disparities.
We present three case studies of groups in the US that experience disparities more commonly associated with LMICs, and note how researchers and communities have partnered together to address the unequal burden of breast cancer in those populations. All three case studies are examined in the context of the socio-ecological model as described by Warnecke and colleagues [21] , and all use a multilevel approach in seeking remedies to the inequities of breast cancer. Table 1 offers a comparison of breast cancer characteristics as well as a snapshot of factors that influence of breast cancer incidence and mortality across the three groups.
African American Women in Urban Chicago, Illinois
Setting and Population Chicago, IL, represents a large Midwestern city that has 77 community areas and 2.7 million residents [22] . Chicago has one of the largest urban African American communities in the US, with 31% of residents identifying as African American [22] . With regard to demographics, approximately 15% have not completed a high school education, over 30% are living in poverty, and 10% have no health insurance [23] . African Americans have largely lived in the same South and West Chicago neighborhoods due to societal and community forces [24] .
Breast Cancer Characteristics Similar to national patterns, breast cancer incidence rates have begun to converge between African American and NLW women living in Chicago and surrounding areas [25] . African American women in Chicago also appear to be more likely to be diagnosed with ER/PR negative tumors relative to NLW counterparts, in line with national findings [26, 27] . Late-stage breast cancer diagnoses represented approximately a third of all cases among African American and NLW women living in Chicago during 2005-2014 [25] . West African ancestry has also been linked to a greater risk for late stage at diagnosis among Chicago-based African American breast cancer patients [26] .
Disparities in breast cancer mortality rates have been welldocumented by Chicago-based working groups; 17 of the 20 community areas with the highest breast cancer mortality in Chicago are predominantly African American [28] . These studies have reported dynamic changes in mortality disparities between 1990 and 2018 [29] [30] [31] [32] [33] [34] [35] [36] , with increased disparity in outcomes during the early 1990s and 2000s, and a shift in the mid-2000s towards a reduction in these disparities. Recent studies have suggested a significant decline in breast cancer mortality among Chicago-based African Americans, with an annual decrease of 1.5% per year between 1999 and 2013. A decline in breast cancer disparities can also be seen, wherein the disparity between African American and NLW women in Chicago was approximately 1.5 between 1995 and 2005 and was 1.4 between 2006 and 2013 [36] . While this trend is promising, more nuanced analyses have suggested heterogeneity in this reduction both by age and specific community areas/neighborhoods [28, 37] . For example, the NLW: African American breast cancer mortality rate ratio for women younger than 40 years old in Chicago is 2.57, whereas the NLW: African breast cancer mortality rate for women who are older than 65 is 1.19 [37] , suggesting greater disparities for younger African American women.
Screening mammography and its effects on Chicago-based racial disparities in late-stage diagnoses and mortality represent a complex picture. Similar to national trends, Chicagospecific data from the Behavioral Risk Factor Surveillance System (BRFSS) suggests that African American and NLW women have relatively similar rates of screening mammography uptake (78-80%) [38] , and research suggests that Chicago-based African American women are less likely to overestimate mammography history relative to other ethnic minorities in Chicago [39] . In Chicago, recent efforts have focused on quality of screening mammography and other breast cancer care, which may drive local disparities [40] [41] [42] [43] [44] [45] [46] [47] [48] . These studies collectively suggest disparities in late-stage diagnoses and mortality may persist, even when there are no differences in breast cancer care uptake, if quality in care differs.
Breast Cancer Barriers Barriers to high-quality care for Chicago-based African American women exist at intrapersonal, interpersonal, and contextual levels, as shown in the socioecological model ( Fig. 1 ) [47] . At the intrapersonal level, cultural misconceptions, lack of knowledge, and cancer fatalism/ fear have been identified as factors contributing to decisions to not seek care/receipt of a late-stage diagnosis [49] [50] [51] [52] . At the interpersonal level, trust in and accessible communication with regular doctors and cancer care specialists have been identified as important [49, 50, 53] . Relative to other areas, a substantial amount of work has focused on the relationship between late-stage diagnosis and the adverse effects of neighborhood social environment and distance to primary care clinics [54] [55] [56] [57] .
Efforts to Intervene A substantial amount of transdisciplinary work has been dedicated to eliminating the disproportionate breast cancer burden among Chicago-based African American women. Of these, the Metropolitan Chicago Breast Cancer Task Force is the best known and was developed by academic, community, and clinical partners to address breast cancer inequities through political advocacy, direct services, and public health surveillance [58, 59] . Local researchers have characterized disparities through observational studies [21, 27, 44-46, 51, 59] and have implemented intervention studies largely focused on patient navigation [40, 47, [60] [61] [62] [63] [64] and those committed to community education [65] [66] [67] [68] [69] [70] . Most efficacious are patient navigation efforts which take women through the process of both screening and treatment. Local grassroots organizations have implemented continuous support and resources for local African American women (e.g., Women on Top of Their Game, Sisters Working It Out). The majority of the research described above has been a result of the National Institutes of Health's commitment to cancer equity through Centers for Population Health and Health Disparities (CPHHD) Initaitive [21] , including one CPHHD Center that lasted 10 years in Chicago. Chicago is also a pilot city for the Susan G. Komen's African American Health Equity Initiative, launched in 2016, which has the goal of reducing breast cancer mortality disparities by 25% within 5 years of program implementation (no data available at this time). Program implementation includes building trust and a trust presence in the [72] .
Breast Cancer Characteristics In 2010-2014, the average annual breast cancer incidence rate in Appalachia Ohio was lower than that for non-Appalachia Ohio (134.8 per 100,000 women vs 153.7 per 100,000 women) [73] . Mortality rates are high in certain Appalachian counties in Ohio (Adams, Harrison, Mahoning, Monroe, Washington), compared to other similar Ohio counties. The prevalence of mammography screening in the past 2 years among women aged 50 to 74 years varies according to annual household income and educational attainment (both of which, as mentioned above, are lower in Appalachia Ohio, compared to non-Appalachia Ohio), ranging from 67 to 84% [74] . The percentage of women diagnosed with late-stage disease in Appalachia Ohio is 28.5%, compared to 28.9% in non-Appalachia Ohio; however, slightly more women in Appalachia Ohio were diagnosed with an unstaged breast cancer (3.0 versus 2.1%) [74] .
Breast Cancer Barriers Barriers to receiving prompt and quality breast cancer services in Appalachia Ohio are centered at multiple levels as defined in the socio-ecological model (Fig.  1) . First, individuals often have fatalistic views about cancer, undermining the ability of early detection tests to be effective [75, 76] . Secondly, socioeconomic factors (both at the individual and community levels) impact the ability of residents to have insurance coverage for mammography and treatment [76, 77] . Thirdly, access to screening and treatment is limited in this region: six of the 32 counties have no mammography facilities and 12 have only one in the entire county. In addition, treatment facilities are sparse [77] . Geographic distances make travel to medical facilities difficult especially with the lack of public transportation and road conditions being subject to adverse weather. [78, 79] . They are also more likely to be uninsured than the general population and, consequently, have limited access to health care.
Efforts to Intervene
Breast Cancer Characteristics Latina women in the US overall are less likely to be diagnosed with any breast cancer (91.1/ 100,000) compared to NLWs (127.3/100,000) and African American women (118.4/100,000) [10] . However, it remains the most common cancer among this ethnic group [10] , and compared to NLWs, Latinas demonstrate a higher breast cancer incidence to mortality ratio [11] . Latinas also experience high rates of diagnosis with aggressive sub-types of breast cancer for which fewer treatment options exist and lower 5-year survival rates are observed [13] . Furthermore, Latina women born in the US who are more acculturated are up to six times more likely to be diagnosed with breast cancer than foreign-born, less acculturated Latinas [20, 80] . [85] . Latinas are less likely than NLWs to obtain routine screening mammography, resulting in later stages of diagnosis, worse prognosis, and shorter survival [86] . In addition to inadequate screening, once diagnosed, Latinas are also more likely to experience delays in initial treatment as well as low levels of initiation and adherence to adjuvant therapy, factors associated with increased breast cancer mortality [87] [88] [89] [90] [91] [92] .
Breast Cancer Barriers Latinas in the Lower Yakima Valley experience unique and multilevel, socially and structurally determined barriers to breast cancer screening and treatment that contribute to poor breast health outcomes. Although data available indicates that breast cancer incidence and mortality in Franklin, Benton, and Yakima counties are lower than the national average, it is likely that the burden of breast cancer is higher than the statistics indicate for the reasons discussed above. Latinas here suffer disproportionately from determinants that impact breast health, such as poverty, low levels of educational attainment, insurance status and language barriers as discussed above [22] . These factors contribute to lack of understanding about where and how often to obtain screening mammography, a problem often exacerbated by communication barriers and a lack of culturally and language-appropriate materials available about breast cancer screening and treatment. Indeed, living in poverty, low levels of education, and lack of health insurance are associated with lower rates of screening and shorter cancer-specific survival [93] [94] [95] . In addition to unique communication needs [96] , fear and mistrust of the medical system, often related to documentation status, also influence this population's adherence to breast cancer screening, treatment, and follow-up care [96] . Finally, in this rural area, access to care may be constrained by lack of transport to distant care facilities.
Efforts to Intervene The Fred Hutchinson Cancer Research
Center has partnered with community organizations across Washington State, including those in the Lower Yakima Valley, to address factors that contribute to disparate breast cancer outcomes among Latinas using culturally informed interventions. Through a community-based participatory approach, in which the community members are involved in each phase of research [97] , researchers train promotores, bilingual and bicultural lay health workers from the community, to educate Latinas in the Yakima Valley about breast cancer. Promotores travel to study participants' homes, where they facilitate home health parties (HHPs), engaging women in discussions about breast cancer screening and treatment. The HHPs often involve Latina women's larger social and familial networks, and are designed to match women's language, dispel myths, and build on their current understanding of breast cancer. The promotora-led HHPs have resulted in improved knowledge about breast cancer, increased report of discussions with doctors regarding mammograms, and increased intention to obtain a mammogram [98] . In addition, the HHPs demonstrated significant increases in knowledge as well as increased interactions with friends and family regarding breast cancer screening [99] . In attempts to address disparities further along the breast cancer care continuum, researchers and community members have partnered to facilitate survivor support groups to address adherence to adjuvant treatment and quality of life among Latina survivors. Support groups offer educational components as well as interventions to bolster social support and quality of lifewhich have been shown to be lacking among Latina breast cancer patients and survivors [100] [101] [102] -with a long-term goal of reducing rates of recurrence and mortality [103] .
Discussion
The case studies presented here characterize disparate pockets of women in the US who experience difficulties in screening, detection, treatment, and survival of breast cancer. As shown in Fig. 1 , these specific health disparities are consequences of factors at multiple levels. Although all are residents of an HIC, they lag behind the average screening, detection, treatment, and survival rates of the average NLW women in the US regardless of the facilities and treatment available in the HIC, they experience many of the same outcomes as women residing in LMICs. That such areas exist in the US, an HIC with widely available screening through mammography and state-of-the-art treatment, is a travesty. Yet, it is obvious from our case studies that race, ethnicity, culture, rural residence, insurance status, and intrapersonal and interpersonal barriers contribute to these disparities.
The multilevel interventions across the three communities described here have yielded some success in bolstering breast cancer awareness and education, increasing screening rates, and potentially reducing disparities in breast cancer. [36, 37, 98, 99] However, much work remains to reduce the burden of breast cancer among these and other underserved women throughout the US. Across all three cases, poverty, lack of education and awareness about breast cancer, and lack of access to high-quality care represent persistent challenges to closing the gap in breast health disparities. In Chicago, the apparent disparities between NLW and African American women under 50 in Chicago who are diagnosed with breast cancer suggests that more attention should be given to screening guidelines for women of African descent. Additionally, the city continues to be afflicted by adverse effects of neighborhood factors, such as segregation, that impact breast health disparities. In Appalachia, mobile mammography vans have helped bolster screening rates, but the low mammography capacity in the region remains, contributing to increased late-stage diagnoses among women there. In the Yakima Valley, language barriers, culturally held stigma, poverty status, and access to care impact women's treatment initiation and adherence to adjuvant therapies. These factors, all of which are represented in Warnecke's model, represent areas for future work.
In terms of addressing disparities, all three case studies note the importance of working with communities at a variety of levels of influence. Consistent with a community-based participatory research approach, the case studies appear to recognize that working with people is the best way to address the problem of disparities. Whether it is educating individuals, assisting with logistics including finances, or arranging treatment, working with a community's resources makes it feasible to identify potential solutions to breast cancer disparities. Changing the disparities is not a single-level strategy; rather, it takes participation at the community, clinic, cultural, and societal level to achieve equity.
From the three case studies, it is clear that unconventional approaches are necessary to reach such underserved women. Rather than focusing on office reminder systems and general media blitzes on mammography, these three studies used a "meeting the women where they are" strategy; that is, the researchers went to the communities to determine how best to reach the underserved populations. For example, Chicago-based academic, community, and clinic partners, as well as national partners, worked to address the disproportionate rates of breast cancer mortality that local African American women face by increasing access to high-quality locally available mammography, ensuring mammography quality surveillance occurs regularly, and addressing the multilevel barriers African American women face through patient navigation.
In Appalachia, rural conditions and limited access to screening facilities make breast screening inaccessible to many residents of the Appalachian counties. Combined with the fatalistic views of many women, it is understandable that few take advantage of screening for early detection. Further, poverty and the associated lack of insurance coverage makes it clearer why women suffer disparities of screening, detection, treatment, and survival. Through a Susan G. Komen Foundation grant, researchers work with communities and clinics to identify women in need of mammography and link them to patient navigation and appointments at either a mammography facility or a hospital-sponsored mammovan to obtain breast cancer screening. The patient navigators ensure that women with a positive screen seek appropriate treatment.
In the Lower Yakima Valley, community input resulted in the identification and/or training of promotores, or lay health workers, to address disparities in screening and treatment. The home health party model used by the promotores is successful in increasing women's knowledge of breast cancer and intention to be screened. The promotores also act as patient navigators, helping women find resources (for example, through the Breast, Cervical, and Colon Health Services) to pay for the screening. Researchers in the Lower Valley also have conducted survivor support groups to assist women who are breast cancer survivors. In this way, the entire continuum of screening, detection, treatment, and survivorship is covered.
Education can help women overcome the intrapersonal and interpersonal barriers to screening; it can also help women understand and mitigate some of the cultural barriers. Mammovans and assistance in traveling to screening facilities can reduce some of the geographic barriers. One remaining barrier is financing for screening. In terms of the future, policy interventions can be useful in removing this barrier. Studies from the effects of the Affordable Care Act indicate that when screening is covered by insurance, all groups of individuals, from the very poor to those suffering low education, take advantage of the screening services [104] [105] [106] [107] . Policies to provide such coverage should continue. Patient navigation and resources to provide such navigation appear to reduce barriers and therefore should also be employed. Patientcentered medical homes are taking advantage of this strategy with some success [108, 109] .
Conclusion
Although HICs have reduced mortality of breast cancer compared to LMICs, there remain significant inequities in the US system. These inequities, as described in these case studies, can be addressed, but concerted efforts are needed to ensure that all have access to equitable systems of screening, detection, treatment, and survivorship. Future research is needed to identify other strategies that will alleviate the inequities.
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